ENYO Pharma
Latest round
- Series C
Last raised
- Jan 2024
Total raised
- $31M
Investors
- 10
About ENYO Pharma
Founded in 2014 and based in Lyon, France, ENYO Pharma SA operates as a developer of drug treatments using fibrolytic and anti-inflammatory qualities for illnesses with compromised kidney function. The company's headquarters is located in Lyon, France, a hub of biomedical innovation, with additional research and development facilities in the United States and the United Kingdom. Enyo Pharma's product pipeline is focused on the development of novel small-molecule and biologic therapies for a range of complex and rare diseases, including liver diseases, metabolic disorders, and autoimmune conditions. One of Enyo Pharma's lead product candidates is a first-in-class small-molecule therapy for the treatment of non-alcoholic steatohepatitis (NASH), a progressive liver disease that is becoming increasingly prevalent globally. This investigational therapy has demonstrated promising results in preclinical studies and is currently undergoing clinical evaluation. In addition to its NASH program, Enyo Pharma is also advancing several other drug candidates targeting a variety of disease areas, including rare genetic disorders and chronic inflammatory conditions. Enyo Pharma generates revenue primarily through research and development collaborations, licensing agreements, and government grants.
Who invested in ENYO Pharma
10 investors across 3 rounds
See all investors in ENYO Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ENYO Pharma
Who invested in ENYO Pharma?
ENYO Pharma has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ENYO Pharma raised?
ENYO Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ENYO Pharma last raise money?
ENYO Pharma's most recent round on record is a Series C, in Jan 2024.
What does ENYO Pharma do?
Founded in 2014 and based in Lyon, France, ENYO Pharma SA operates as a developer of drug treatments using fibrolytic and anti-inflammatory qualities for illnesses with compromised kidney function.
Where is ENYO Pharma headquartered?
ENYO Pharma is headquartered in Lyon, France.
Which VCs invest in companies like ENYO Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at ENYO Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like ENYO Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.